These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


175 related items for PubMed ID: 7018412

  • 21. Anomalous observations on IPV and OPV vaccination.
    John TJ.
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [Abstract] [Full Text] [Related]

  • 22. SALK poliomyelitis vaccine information.
    J Natl Med Assoc; 1955 May; 47(3):183-4. PubMed ID: 14368292
    [No Abstract] [Full Text] [Related]

  • 23. Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy.
    Dragunsky EM, Ivanov AP, Wells VR, Ivshina AV, Rezapkin GV, Abe S, Potapova SG, Enterline JC, Hashizume S, Chumakov KM.
    J Infect Dis; 2004 Oct 15; 190(8):1404-12. PubMed ID: 15378432
    [Abstract] [Full Text] [Related]

  • 24. [Findings on the success of vaccination and revaccination with live and inactivated vaccines against poliomyelitis].
    Dostal V, Haenzel I, Sturm W.
    Schweiz Med Wochenschr; 1969 Sep 13; 99(37):1322-4. PubMed ID: 4309326
    [No Abstract] [Full Text] [Related]

  • 25. Review of the Louisiana State Board of Health experience with the use of Salk vaccine and comments on the Sabin oral polio vaccine.
    HEDMEG A.
    J La State Med Soc; 1963 Feb 13; 115():41-7. PubMed ID: 13963684
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [The battle in Madrid over poliomyelitis vaccines (1963): science, ideology and power in the first mass immunization campaign in Spain].
    Tuells J.
    Gac Sanit; 2019 Feb 13; 33(5):480-484. PubMed ID: 30031656
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Recent improvements in polio and pertussis vaccination policy in Israel, 2005.
    Rishpon S.
    Isr Med Assoc J; 2006 May 13; 8(5):319-21. PubMed ID: 16805229
    [Abstract] [Full Text] [Related]

  • 32. [Poliomyelitis: vaccination is still important].
    Pregliasco F, Minolfi V, Binda S, Andreassi A, Profeta ML.
    Ann Ig; 1994 May 13; 6(4-6):675-84. PubMed ID: 8611242
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [The perspective of global eradication of poliomyelitis].
    Knolle H, Egli A, Candrian U.
    Gesundheitswesen; 2004 Jan 13; 66(1):1-6. PubMed ID: 14767784
    [Abstract] [Full Text] [Related]

  • 35. Poliomyelitis vaccines in Belgium: 20 years of experience.
    Andre FE.
    Dev Biol Stand; 1979 Jan 13; 43():187-93. PubMed ID: 230109
    [No Abstract] [Full Text] [Related]

  • 36. Poliomyelitis in Japan during the period 1962-68 after the introduction of mass vaccination with Sabin vaccine.
    Takatsu T, Tagaya I, Hirayama M.
    Bull World Health Organ; 1973 Jan 13; 49(2):129-37. PubMed ID: 4545320
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.